The NASH group met the biochemical criteria characteristic of the disease because they had elevated levels of AST, ALT, and glucose [50], alongside reduced levels of liver function-associated creatinine [51]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.